The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of radiomics as a predictor of tumor hypoxia and response to anti-PD-1 mab treatment (IO) in recurrent/metastatic HNSCC patients (R/M).
 
Dan Paul Zandberg
Consulting or Advisory Role - Blueprint Medicines
Research Funding - Aduro Biotech (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); GlaxoSmithKline (Inst); ISA Pharmaceuticals (Inst); Merck Sharp & Dohme (Inst)
 
Serafettin Zenkin
No Relationships to Disclose
 
Murat AK
No Relationships to Disclose
 
Priyadarshini Mamindla
No Relationships to Disclose
 
Vishal Peddagangireddy
No Relationships to Disclose
 
Ashley V. Menk
No Relationships to Disclose
 
Greg Delgoffe
Leadership - Novasenta
Stock and Other Ownership Interests - BlueSphere; Novasenta
Honoraria - Merck Sharp & Dohme; Pieris Pharmaceuticals
Consulting or Advisory Role - Century Therapeutics; Kalivir Immunotherapeutics; Novasenta; Pieris Pharmaceuticals
Research Funding - Bluebird Bio; Kalivir Immunotherapeutics; Novasenta; Pfizer; Pieris Pharmaceuticals; TCR2 Therapeutics
Patents, Royalties, Other Intellectual Property - Astellas Pharma; Kalivir Immunotherapeutics
Travel, Accommodations, Expenses - Pieris Pharmaceuticals
 
Maria A Velez
No Relationships to Disclose
 
Angen Liu
No Relationships to Disclose
 
Heath Devin Skinner
No Relationships to Disclose
 
Robert L. Ferris
Stock and Other Ownership Interests - Novasenta
Consulting or Advisory Role - Aduro Biotech; Bristol-Myers Squibb; EMD Serono; Macrogenics; Merck; Novasenta; Numab; Pfizer; Sanofi; Zymeworks
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Novasenta; Tesaro
 
Rivka R. Colen
No Relationships to Disclose